ClinicalTrials.gg
Status unknownNCT05945433Updated Jul 14, 2023

Anovo™ Surgical System - Registry Study

An observational study in GYN Disorders, sponsored by Momentis Surgical. Status unknown at 1 site in United States. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-14.

Sponsored by Momentis Surgical · Observational

The sponsor has not verified this record recently (last verified Jul 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
300
Sex
Female
01

Study summary

To collect Real-World Data (RWD) on the ongoing safety and effectiveness of the anovo Surgical system in transvaginal gynecological laparoscopic surgical procedures and to obtain information on the impact of the anovo Skills Development Pathway on user behavior and performance (where performance is measured by the learning curve of the surgeons and procedure outcomes).

Read the detailed description

Specific Aims:

  1. To collect RWD from surgeons with varying experience and expertise on their learning curve and time to achieve competency, and as such assess the success of the Skills Development Pathway.
  2. Collect safety information and analyze the causality between type and frequency of adverse events to surgeons' experience.
  3. Evaluate the effectiveness of the device while minimizing bias by enrolling "all comers", which will represent the general patient population.
02

Conditions studied

  • GYN Disorders
03

In context

Genital Diseases, Female

161 studies on the registry are indexed under Genital Diseases, Female; 31 are open to participants now.

This study's planned enrollment of 300 is above the median of 200 across 37 observational studies indexed under Genital Diseases, Female.

Browse Genital Diseases, Female studies →

Lead sponsor

Momentis Surgical is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All patients receiving gynecological surgical procedure with the anovo Surgical System by their surgeon will be offered to participate in the registry. To be eligible to participate in the registry, patients must understand and sign the informed consent form, including data privacy authorization, indicating their consent to participate in the registry study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

All patients receiving gynecological surgical procedure with the anovo Surgical System by their surgeon will be offered to participate in the registry.

Inclusion criteria

Inclusion Criteria:

  • patients must understand and sign the form, including data privacy authorization, indicating their consent to participate in the registry study.
  • willing to complete post-operative questionnaire

Exclusion criteria

Exclusion Criteria:

-none

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
8 Weeks
Patient registry
Yes

Groups and cohorts

  • Patients undergoing gynecological surgical procedure with the anovo Surgical System

    Device: anovo™ Surgical System

Interventions

  • Deviceanovo™ Surgical System

    The anovo Surgical System is an endoscopic instrument control system that is intended to assist in the accurate control of the Instrument ARMS during single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures.

06

What researchers measure

Primary outcomes

  1. Conversion rate to open or laparoscopic approach

    Time frame: Procedure

  2. Rate of Unanticipated Adverse Device Effect

    Time frame: 8 Weeks Follow Up

Secondary outcomes

  1. Surgery time (minutes)

    Time frame: Procedure

Other outcomes

  1. Surgeon Learning Curve (surgery time against number of operations performed, considering frequency of cases and surgery difficulty)

    To be reported as a continuous curve (plot per surgeon), and as the mean difference in surgery times between during learning curve and after learning curve stages (stages defined as before the surgeon achieves a steady state surgical time and after the surgeon achieves the steady state)

    Time frame: Procedure

  2. Surgeon Safety Curve (cumulative UADEs against number of operations performed)

    Time frame: Procedure

  3. User Skills Development Survey

    Time frame: Procedure

07

Study locations

1 of 1 sites recruiting
  • AdventHealth
    Celebration, Florida 34747, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05945433
Lead sponsor
Momentis Surgical
Responsible party
Sponsor
First posted
Jul 14, 2023
Start date
Jun 28, 2023
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Jul 14, 2023

Study contacts

Sharon H Branch
Contact
sharon.branch@momentissurgical.com
9543033777
Matthew McKittrick
Contact
matthew.mckittrick@momentissurgical.com
6106745544

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion